WU Yiling's "collateral disease" theory guides the staged diagnosis and treatment of ulcerative colitis by "combining disease and syndrome"
-
摘要: 中国工程院院士吴以岭提出“络病”学说，系统构建络病理论体系，研究内容针对各类难治性疾病的诊治，其诊疗模式具有疗效确切、不良反应少、安全持久的独特优势。溃疡性结肠炎作为全球难治性疾病之一，严重影响患者的生存质量，临床治疗原则是控制炎症、缓解症状、提高生活质量。近年来，中医药通过整体观念，进行个体化治疗溃疡性结肠炎取得了较为满意的临床疗效，而“络病”学说的提出，是对溃疡性结肠炎诊疗系统的进一步完善。本文聚焦于中医学“络病”理论研究，进行“病证结合”的诊疗方式沟通中西医桥梁，采取综合治疗手段。目的是建立溃疡性结肠炎的“络病”病证结合体系，及时有效辨别肠络损伤病变，指导UC疾病的分期诊疗及临床用药。Abstract: WU Yiling, an academician of the CAE Member, put forward the theory of "collateral disease", and systematically constructed the theoretical system of collateral disease. The research content is aimed at the diagnosis and treatment of various refractory diseases. Its diagnosis and treatment mode has unique advantages of accurate efficacy, less adverse reactions, and safety and durability. Ulcerative colitis(UC), as one of the global refractory diseases, seriously affects the quality of life of patients. The clinical treatment principle is to control inflammation, alleviate symptoms and improve the quality of life. In recent years, Chinese medicine has achieved satisfactory clinical efficacy in individualized treatment of UC through the overall concept, and the "collateral disease" theory is to further improve the diagnosis and treatment system of UC. This article focuses on the theoretical research of "collateral disease" in Traditional Chinese Medicine, and carries out the diagnosis and treatment of "disease syndrome combination" to communicate the bridge between Traditional Chinese Medicine and Western medicine, and adopt comprehensive treatment methods. The objective is to establish a disease syndrome combination system of "collateral disease" in UC, to timely and effectively identify the lesions of intestinal collateral injury, and to guide the staged diagnosis and treatment of UC and clinical medication.
-
-
[1] 中国中西医结合学会. 溃疡性结肠炎中西医结合诊疗专家共识[J]. 中国中西医结合杂志, 2023, 43(1): 5-11. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202301001.htm
[2] 李沐涵, 李景南. 溃疡性结肠炎癌变相关机制研究进展[J]. 中国中西医结合消化杂志, 2023, 31(4): 243-249. http://zxpw.cbpt.cnki.net/WKD2/WebPublication/paperDigest.aspx?paperID=a2881a8e-28b7-45a5-be53-00d582ac29e6
[3] 陈士奎. 中西医结合防治疑难病研究举世瞩目[J]. 疑难病杂志, 2021, 20(8): 757-760. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ202108001.htm
[4] 张筱军. 吴以岭教授治疗络病用药经验[J]. 中国中医急症, 2005, 14(12): 1196-1196. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ200512045.htm
[5] 吴以岭. 络病学说形成与发展的三个里程碑(二)[J]. 疑难病杂志, 2004, 3(3): 149-151. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ200403011.htm
[6] 别玉龙, 赵福海, 史大卓. 浅论中西医现代临床"病证结合"思维模式[J]. 中西医结合心脑血管病杂志, 2022, 20(3): 561-562. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202203039.htm
[7] 李红蓉, 吴以岭. 络病研究的传承与创新[J]. 南京中医药大学学报, 2022, 38(12): 1075-1085. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202212001.htm
[8] 刘坤, 徐菁, 马竹芳. 溃疡性结肠炎血清IGF-1、IL-6、IL-18表达水平的变化及意义[J]. 临床和实验医学杂志, 2023, 22(2): 140-143.
[9] 盛天骄, 谭林深, 巩阳, 等. "温清共用法"治疗儿童溃疡性结肠炎的疗效及策略分析[J]. 中国中西医结合消化杂志, 2022, 30(11): 799-803. http://zxpw.cbpt.cnki.net/WKD2/WebPublication/paperDigest.aspx?paperID=b950aabd-35bd-423a-9318-8a91a40b4496
[10] 凡杭, 聂安政, 包莉, 等. 藿香化学成分与药理作用研究进展[J]. 中国野生植物资源, 2021, 40(11): 45-53. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSZ202111009.htm
[11] 王懿, 王惠娟. 活血化瘀法治疗溃疡性结肠炎的研究进展[J]. 中国中西医结合消化杂志, 2023, 31(1): 72-76. http://zxpw.cbpt.cnki.net/WKD2/WebPublication/paperDigest.aspx?paperID=3147319f-87e1-47f4-89e9-76f53804c9fc
[12] 李伟霞, 泥文娟, 王晓艳, 等. 当归化学成分、药理作用及其质量标志物(Q-marker)的预测分析[J]. 中华中医药学刊, 2022, 40(6): 40-47, 274. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202206008.htm
[13] 张妍妍, 韦建华, 卢澄生, 等. 桃仁化学成分、药理作用及质量标志物的预测分析[J]. 中华中医药学刊, 2022, 40(1): 234-241. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202201056.htm
[14] 姜秋, 王玲娜, 刘谦, 等. 水蛭的炮制历史沿革、化学成分及药理作用研究进展[J]. 中国中药杂志, 2022, 47(21): 5806-5816. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202312018.htm
[15] 陈雪吟, 康福琴, 杨丽虹, 等. 中医湿证与微炎症状态的相关性探讨[J]. 中医杂志, 2021, 62(21): 1841-1845, 1854. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202121001.htm
[16] 梁峻尉, 白文筠, 王晓燕, 等. 基于"虚毒"理论观察中西医结合疗法对脾虚湿蕴型溃疡性结肠炎活动期的临床疗效[J]. 时珍国医国药, 2022, 33(4): 902-906. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY202204037.htm
[17] 娄莹莹, 李佃贵, 霍永利, 等. 溃疡性结肠炎特色病机"浊毒损膜伤络"及其意义[J]. 中国中西医结合杂志, 2022, 42(6): 749-753. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202206019.htm
[18] 张天涵, 沈洪, 朱磊. 溃疡性结肠炎大肠湿热证与血液高凝状态的相关性研究[J]. 中华中医药杂志, 2020, 35(8): 4156-4158. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202008099.htm
[19] 魏丽彦, 韩雪飘, 郭珊珊, 等. 运用风药治疗缓解期溃疡性结肠炎经验[J]. 环球中医药, 2021, 14(8): 1504-1507. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202108047.htm
[20] 李盈, 杨豪杰, 干丹, 等. 祛瘀生新方对溃疡性结肠炎患者粪便病毒多样性的影响[J]. 辽宁中医杂志, 2022, 49(2): 86-89, 221-222. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY202202025.htm
[21] 马慧洁, 吴娜. 祛瘀生新方联合益生菌治疗溃疡性结肠炎的疗效分析[J]. 广州中医药大学学报, 2021, 38(12): 2592-2597. https://www.cnki.com.cn/Article/CJFDTOTAL-REST202112008.htm
[22] 沈思辰. 祛瘀生新方对葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠模型Th17/Treg细胞分化的调控机制研究[D]. 上海: 上海中医药大学, 2020.
[23] 吴闯, 王振宜, 张海岩, 等. 扶正祛瘀法治疗溃疡性结肠炎研究[J]. 长春中医药大学学报, 2012, 28(3): 441-443. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201203033.htm
-
计量
- 文章访问数: 465
- PDF下载数: 315
- 施引文献: 0
下载: